British Woman Becomes ‘Star’ for Saving Starving Owl

A tawny owl. (Getty Images)
A tawny owl. (Getty Images)
TT

British Woman Becomes ‘Star’ for Saving Starving Owl

A tawny owl. (Getty Images)
A tawny owl. (Getty Images)

A woman has become an unlikely social media star in her Cornish village - all thanks to a family of tawny owls, reported the BBC on Friday.

Diane Knight had set up a CCTV system so she could watch the owls nesting in her barn near Carnon Downs, Cornwall.

But when the male owl stopped bringing the female food, Knight stepped in.

Her work to supply the owl and the baby owlet with dead mice has proved popular on the village's Facebook page.

Knight's owl obsession started through watching the pair of tawny owls on a nest-cam she had set up.

She said the male owl was injured in a fight with a rival owl and stopped bringing the female the food she needed while sitting on her single egg.

Knight, 69, took advice and started buying dead mice, stocked as snake food by local pet shops, soon racking up a bill of more than £100.

She was told to place the mice on a nearby beam to avoid disturbing the nest, which involved climbing up a 15ft (4.5m) ladder.

She also started to share stills and video on the Carnon Downs And Surrounding Area Notice Board on Facebook and was inundated with offers of help from followers.

"They've been brilliant," she said. "One gentlemen paid for 30 and another lady she paid for 20 so I've got 50 dead mice waiting for me.

"We've got enough now, we've got a freezerful," she added, according to the BBC.

Her regular owl updates on Facebook are attracting dozens of likes and comments.

"I am a little bit addicted to it myself, I haven't watched television for months," she said.

"I cannot believe how one little owlet has brought the community together.

"I went to the dentist and the first thing they said to me is 'Are you the Owl Lady of Carnon Downs?'"

Knight has named the owlet Dorothea - Dotty for short - and is hoping the young bird is soon learn to fly, leave the nest and hunt for its own mice dinners.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”